Muhammad Badar
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Global Health and Epidemiology 6
-
- Tuberculosis Research and Epidemiology 3
- Co-authors
- Peter P. Mueller (7 shared papers)Muhammad Usman Akbar (4 shared papers)Muhammad Zaheer (3 shared papers)H. Häuser (6 shared papers)Peter J. Behrens (6 shared papers)Muhammad Imran Rahim (3 shared papers)Marc Kieke (4 shared papers)Martin Stieve (3 shared papers)
- Journals
- The Lancet (13 papers)The Lancet Infectious Diseases (6 papers)The Lancet Neurology (4 papers)Journal of Biomedical Materials Research Part A (3 papers)Cellular and Molecular Life Sciences (2 papers)
- Partner nations
- United StatesPakistanGermany
In The Last Decade
Muhammad Badar
56 papers receiving 19.2k citations
Muhammad Badar's Hit Papers
Peers
Comparison fields: 5 of 192
- Applied Microbiology and Biotechnology 625
- Molecular Medicine 671
- Endocrinology, Diabetes and Metabolism 1.6k
- Oncology 1.6k
- Epidemiology 2.1k
Countries citing papers authored by Muhammad Badar
This map shows the geographic impact of Muhammad Badar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Badar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Badar more than expected).
Fields of papers citing papers by Muhammad Badar
This network shows the impact of papers produced by Muhammad Badar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Badar. The network helps show where Muhammad Badar may publish in the future.
Co-authors
The 25 scholars most cited alongside Muhammad Badar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 2 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2997 |
| 3 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1965 |
| 4 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 5 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1679 |
| 6 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 1526 |
| 7 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1152 |
| 8 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 948 |
| 9 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 702 |
| 10 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 687 |
| 11 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 675 |
| 12 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 657 |
| 13 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 318 |
| 14 | Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 215 |
| 15 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 210 |
| 16 | The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories Hit paper breakdown → | 2023 | 128 |
| 17 | Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 116 |
| 18 | Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 87 |
| 19 | Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 78 |
| 20 | Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 78 |
About Muhammad Badar
Muhammad Badar is a scholar working on Health Information Management, Infectious Diseases, Demography, Biomaterials and Microbiology, having authored 62 papers that have together received 19.8k indexed citations. Recurring topics across this work include Global Health and Epidemiology (6 papers), Insurance, Mortality, Demography, Risk Management (6 papers), Cardiovascular Health and Risk Factors (4 papers), Layered Double Hydroxides Synthesis and Applications (4 papers), Global Cancer Incidence and Screening (3 papers), Pneumonia and Respiratory Infections (3 papers), Tuberculosis Research and Epidemiology (3 papers) and Metal-Organic Frameworks: Synthesis and Applications (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (625 citations), Molecular Medicine (671 citations), Endocrinology, Diabetes and Metabolism (1.6k citations), Oncology (1.6k citations) and Epidemiology (2.1k citations). Muhammad Badar has collaborated with scholars based in United States, Pakistan and Germany. Frequent co-authors include Peter P. Mueller, Muhammad Usman Akbar, Muhammad Zaheer, H. Häuser, Peter J. Behrens, Muhammad Imran Rahim, Marc Kieke, Martin Stieve, Gamal A. Elmegeed and Herbert A. Weich. Their work appears in journals such as The Lancet, The Lancet Infectious Diseases, The Lancet Neurology, Journal of Biomedical Materials Research Part A and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.